Presidio Property Trust Inc Preferred Series D

NASDAQ SQFTP

Download Data

Presidio Property Trust Inc Preferred Series D Operating Cash Flow To Current Liabilities for the quarter ending March 31, 2024: 0.14

Presidio Property Trust Inc Preferred Series D Operating Cash Flow To Current Liabilities is 0.14 for the quarter ending March 31, 2024, a 200.05% change year over year. The operating cash flow to current liabilities ratio measures the ability of a company's operating cash flow to cover its current liabilities. It is calculated by dividing the operating cash flow by the current liabilities. This ratio indicates the company's short-term liquidity position and its ability to meet its immediate financial obligations using cash generated from its operations. A higher ratio suggests a stronger ability to cover current liabilities with operating cash flow.
  • Presidio Property Trust Inc Preferred Series D Operating Cash Flow To Current Liabilities for the quarter ending March 31, 2023 was -0.14.
NASDAQ: SQFTP

Presidio Property Trust Inc Preferred Series D

CEO -
IPO Date June 11, 2021
Location United States
Headquarters 4995 Murphy Canyon Road, San Diego, CA, United States, 92123
Employees 15
Sector Real Estate
Industry Reit - diversified
Description

Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. Our office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas, including those that have developed as a result of COVID-19. Presidio owns approximately 6.5% of the outstanding common stock of Conduit Pharmaceuticals Inc., a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development.

Similar companies

ATLCP

Atlanticus Holdings Corp Preferred

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email